TOPLINE: Real-world treatment patterns and outcomes among older patients with follicular lymphoma show significant heterogeneity, with 13,423 Medicare beneficiaries aged ≥ 65 years followed through 2019. Over a median follow-up of 57.1 months, survival rates improved significantly, with mortality risk reduced by 21% and 36% for patients diagnosed in 2006-2011 and 2012-2017…
Leave a Comment Leave a Comment
